MDB Capital Holdings, LLC (NASDAQ:MDBH – Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 1,194 shares, an increase of 80.6% from the November 30th total of 661 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 15,868 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 15,868 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s shares are short sold.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of MDB Capital in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, MDB Capital presently has an average rating of “Sell”.
Get Our Latest Stock Report on MDB Capital
Institutional Trading of MDB Capital
MDB Capital Stock Performance
Shares of NASDAQ:MDBH opened at $3.50 on Friday. The business’s 50 day simple moving average is $3.57 and its two-hundred day simple moving average is $3.80. The firm has a market cap of $35.49 million, a P/E ratio of 3.76 and a beta of 1.08. MDB Capital has a 52-week low of $3.16 and a 52-week high of $7.98.
MDB Capital (NASDAQ:MDBH – Get Free Report) last released its quarterly earnings data on Thursday, November 13th. The company reported ($0.46) EPS for the quarter. The firm had revenue of $1.42 million during the quarter.
About MDB Capital
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.
Featured Stories
- Five stocks we like better than MDB Capital
- Wall Street Stockpicker Names #1 Stock of 2026
- The Best $1 You’ll Spend This Holiday Season
- ALERT: Drop these 5 stocks before January 2026!
- The $650 Million Bet on AI’s Future
- Nvidia x 1,000,000
Receive News & Ratings for MDB Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDB Capital and related companies with MarketBeat.com's FREE daily email newsletter.
